Dawood, A.F.; Al Humayed, S.; Momenah, M.A.; El-Sherbiny, M.; Ashour, H.; Kamar, S.S.; ShamsEldeen, A.M.; Haidara, M.A.; Al-Ani, B.; Ebrahim, H.A.
MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol. Diagnostics 2022, 12, 1762.
https://doi.org/10.3390/diagnostics12071762
AMA Style
Dawood AF, Al Humayed S, Momenah MA, El-Sherbiny M, Ashour H, Kamar SS, ShamsEldeen AM, Haidara MA, Al-Ani B, Ebrahim HA.
MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol. Diagnostics. 2022; 12(7):1762.
https://doi.org/10.3390/diagnostics12071762
Chicago/Turabian Style
Dawood, Amal F., Suliman Al Humayed, Maha A. Momenah, Mohamed El-Sherbiny, Hend Ashour, Samaa S. Kamar, Asmaa M. ShamsEldeen, Mohamed A. Haidara, Bahjat Al-Ani, and Hasnaa A. Ebrahim.
2022. "MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol" Diagnostics 12, no. 7: 1762.
https://doi.org/10.3390/diagnostics12071762
APA Style
Dawood, A. F., Al Humayed, S., Momenah, M. A., El-Sherbiny, M., Ashour, H., Kamar, S. S., ShamsEldeen, A. M., Haidara, M. A., Al-Ani, B., & Ebrahim, H. A.
(2022). MiR-155 Dysregulation Is Associated with the Augmentation of ROS/p53 Axis of Fibrosis in Thioacetamide-Induced Hepatotoxicity and Is Protected by Resveratrol. Diagnostics, 12(7), 1762.
https://doi.org/10.3390/diagnostics12071762
